The study reveals that fewer than 1 in 1,000 adolescents with commercial insurance received gender-affirming medications, demonstrating the rarity of such care among youth.
Lead author Landon Hughes emphasized that inappropriate use of gender-affirming care is not observed, and it occurs much less frequently than commonly perceived.
The study utilized extensive insurance data across all states, covering over 5 million patients, indicating the low percentage of adolescents receiving gender-affirming treatment.
Dr. Scott Leibowitz highlighted the necessity for understanding the true rates of gender-affirming care, as the study adds valuable evidence for best practices for gender-diverse youth.
#transgender-youth #gender-affirming-care #healthcare-statistics #puberty-blockers #hormone-treatment
Collection
[
|
...
]